Home » Topics » Disease categories and therapies » Infection

Infection
RSS

German launch announced for flu drug

Dec. 20, 1999

WHO takes over to ensure continued availability of antitrypanosomal agent

Dec. 20, 1999

Antiviral compounds useful against picornaviruses and hepatitis viruses synthesized at Lilly

Dec. 17, 1999

Relenza now available in Canada for treament of influenza

Dec. 17, 1999

SmithKline Beecham seeks approval of Factive in U.S.

Dec. 16, 1999

Sordaricin derivatives with useful spectrum antifungal of activity

Dec. 16, 1999

Millennium delivers ninth target to Wyeth-Ayerst for screening

Dec. 15, 1999

Bayer's Avelox approved in U.S. for treatment of respiratory illnesses

Dec. 14, 1999

Agouron's AG-7088 successfully completes phase II rhinovirus trial

Dec. 14, 1999

Novel truncated indolicidin analogues display broad-spectrum antimicrobial activity

Dec. 14, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...